Pain behaviors produced by capsaicin: Influence of inflammatory mediators and nerve injury

被引:31
作者
Sawynok, J [1 ]
Reid, A [1 ]
Meisner, J [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada
基金
加拿大健康研究院;
关键词
capsaicin; pain behaviors; inflammatory mediators; nerve injury;
D O I
10.1016/j.jpain.2005.09.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present study was undertaken to characterize spontaneous (ie, nonevoked) pain behaviors (flinching, biting/licking) produced by local injections of capsaicin into the rat hindpaw as a model of chemogenic pain, and to determine effects of inflammatory mediators and nerve injury on such behaviors. Capsaicin antagonists are a potential class of novel topical analgesics, and this model may be of value for preclinical screening of novel compounds. Local injections of capsaicin (0.1-30 mu g) into the hindpaw produced flinching and biting/licking behaviors over 5 min, and these were reduced by capsazepine, a competitive antagonist for capsaicin at the TRPV1 receptor. Coadministration of noradrenaline (NA), prostaglandin E-2 (PGE(2)), and 5-hydroxytryptamine (5-HT) augmented capsaicin-evoked responses primarily by extending the duration of behaviors. Partial sciatic nerve ligation decreased flinching produced by capsaicin alone, by capsaicin in combination with each of NA, PGE2, and 5-HT, and by formalin. Tibial nerve injury also reduced capsaicin-evoked flinching, and responses to formalin, but spinal nerve ligation did not affect either. These results indicate that (1) spontaneous pain behaviors occur as a result of TRPV1 receptor activation with a different time course than evoked responses, (2) inflammatory mediators augment capsaicin-evoked pain behaviors, and (3) various forms of nerve injury produce different effects on capsaicin-evoked pain behaviors. Perspective: The VR1 receptor is a potential target for development of novel topical analgesics. This study characterized pain behaviors produced by local injections of capsaicin in the presence of inflammatory mediators and following various forms of nerve injury. Results are of interest for the preclinical screening of novel VR1 receptor antagonists. (c) 2006 by the American Pain Society.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 54 条
[1]   Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat [J].
Aley, KO ;
Levine, JD .
NEUROSCIENCE, 2002, 111 (02) :389-397
[2]   Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons [J].
Amaya, F ;
Oh-Hashi, K ;
Naruse, Y ;
Iijima, N ;
Ueda, M ;
Shimosato, G ;
Tominaga, M ;
Tanaka, Y ;
Tanaka, M .
BRAIN RESEARCH, 2003, 963 (1-2) :190-196
[3]   Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel [J].
Carlton, SA ;
Zhou, ST ;
Du, JH ;
Hargett, GL ;
Ji, GC ;
Coggeshall, RE .
PAIN, 2004, 110 (03) :616-627
[4]   Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization [J].
Carlton, SM ;
Coggeshall, RE .
NEUROSCIENCE LETTERS, 2001, 310 (01) :53-56
[5]   The vanilloid receptor: A molecular gateway to the pain pathway [J].
Caterina, MJ ;
Julius, D .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :487-517
[6]   Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition [J].
Chuang, HH ;
Prescott, ED ;
Kong, HY ;
Shields, S ;
Jordt, SE ;
Basbaum, AI ;
Chao, MV ;
Julius, D .
NATURE, 2001, 411 (6840) :957-962
[7]   Biochemical pharmacology of the vanilloid receptor TRPV1 - An update [J].
Cortright, DN ;
Szallasi, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (10) :1814-1819
[8]   STREPTOZOCIN-INDUCED DIABETIC RATS - BEHAVIORAL EVIDENCE FOR A MODEL OF CHRONIC PAIN [J].
COURTEIX, C ;
ESCHALIER, A ;
LAVARENNE, J .
PAIN, 1993, 53 (01) :81-88
[9]   Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy [J].
Cui, JG ;
Holmin, S ;
Mathiesen, T ;
Meyerson, BA ;
Linderoth, B .
PAIN, 2000, 88 (03) :239-248
[10]  
Decosterd I, 2004, ANESTH ANALG, V99, P457